Founded in 1971, Frontenac focuses on lower middle market investments in a number of sectors, including healthcare. Based in Chicago, the firm prefers to make more substantial investments from a dollars perspective in companies with at least $10 million in revenue. Within healthcare, Frontenac targets companies in the provider services and non-reimbursement industries. Companies in its healthcare portfolio include Behavioral Health Group, an operator of outpatient substance abuse treatment centers, primarily for addiction to prescription pain medication, and e+ CancerCare, an operater of outpatient cancer care centers mostly through partnerships with local hospitals and physicians.
Read more about Frontenac at